# Rizatriptan 5 mg for the Acute Treatment of Migraine in Adolescents: A Randomized, Double‐Blind, Placebo‐Controlled Study

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/rizatriptan-5-mg-for-the-acute-treatment-of-migraine-in-adolescents-a-randomized/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Paul Winner,Donald W. Lewis,W. Hester Visser,Kaihong Jiang,S. Ahrens,Judith K. Evans,On Behalf Of The Rizatriptan Adolescent Study Group |
| Citations | 155 |
| DOI | 10.1046/j.1526-4610.2002.02013.x |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W2116593011 |
| PMID | 12005275 |
| Type | article |
| Year | 2002 |

## Paper authors

- [Paul Winner](https://scholariq.org/researchers/paul-winner/)

## Paper journal

- [Headache The Journal of Head and Face Pain](https://scholariq.org/journals/headache-the-journal-of-head-and-face-pain/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Neurological Complications and Syndromes](https://scholariq.org/topics/neurological-complications-and-syndromes/)
- [Traumatic Brain Injury Research](https://scholariq.org/topics/traumatic-brain-injury-research/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.